WASHINGTON, Dec. 10 (UPI) -- The U.S. Food and Drug Administration announced the expansion of the recall of Starcaps-brand dietary supplement to include additional lot numbers.
The FDA said the voluntary recall was initiated by Balanced Health Products Inc. of New York because lot Nos. 82866 and 83801 were found to contain an undeclared ingredient, Bumetanide -- a diuretic available by prescription only, posing the risk of fluid and electrolyte loss and an elevation in uric acid concentrations.
The original recall, announced in November, involved only lot No. 84810. Starcaps are sold in 30 capsule plastic bottles by retail stores nationwide and on the Internet to help "metabolize protein, eliminate bloat, and detoxify your system" as well as helping in weight reduction.
The company said the contamination apparently occurred in Lima, where the raw materials for the product originated.
Consumers with questions can contact the company at 212-794-9793.
The FDA said the voluntary recall was initiated by Balanced Health Products Inc. of New York because lot Nos. 82866 and 83801 were found to contain an undeclared ingredient, Bumetanide -- a diuretic available by prescription only, posing the risk of fluid and electrolyte loss and an elevation in uric acid concentrations.
The original recall, announced in November, involved only lot No. 84810. Starcaps are sold in 30 capsule plastic bottles by retail stores nationwide and on the Internet to help "metabolize protein, eliminate bloat, and detoxify your system" as well as helping in weight reduction.
The company said the contamination apparently occurred in Lima, where the raw materials for the product originated.
Consumers with questions can contact the company at 212-794-9793.
Source : http://www.upi.com/Science_News/2008/12/10/Starcaps-brand_dietary_supplement_recalled/UPI-66641228933811/
No comments:
Post a Comment